Dendritic cell-based vaccines, a promising prospect for ending AIDS and eradication of HIV worldwide: A narrative review on the latest updates

人类免疫缺陷病毒(HIV) 叙述性评论 艾滋病疫苗 病毒学 医学 免疫学 生物 重症监护医学 疫苗试验
作者
Amir Ghaffari Jolfayi,Shiva Alipour,Sarina Aminizadeh,Seyyed Mohammad Yaghoubi,Sepideh Sohrabi,Zahra Ghahramanipour,Amir Azimi,Fateme Yousefimoghadam,Behzad Baradaran
出处
期刊:Vaccine [Elsevier BV]
卷期号:61: 127340-127340 被引量:2
标识
DOI:10.1016/j.vaccine.2025.127340
摘要

Significant challenges are presented as a result of the ongoing HIV/AIDS pandemic, particularly given the ongoing burden of new infections and the lack of a proven treatment. Among other approaches, vaccinations based on Dendritic Cells (DCs) have become a viable tactic in the fight against HIV. These vaccines take advantage of DCs' special capacity to deliver antigens, which makes them crucial mediators between innate and adaptive immune responses. DC-based vaccines seek to offer a prolonged and effective protection against the virus by stimulating immunological responses against HIV-infected cells and activating cytotoxic T lymphocytes (CTLs). This narrative review highlights the recent advancements in DC-based vaccine development for HIV/AIDS. It explores various vaccine strategies, including DC/SHIV fusion vaccines, peptide-pulsed DC vaccines, mRNA-based DC vaccines, and lentiviral vector-modified DC vaccines. These methods have shown promise in preclinical and clinical trials by eliciting strong immune responses, especially by activating HIV-specific T cells and modulating immune checkpoints like PD-1/PD-L1 and CTLA-4. The review emphasizes how these vaccines can enhance immune responses, reduce viral load, and potentially contribute to a functional cure for HIV. This study aims to offer a thorough update on the process and obstacles in DC-based vaccine development for HIV/AIDS. This review also addresses clinical trials and future directions for optimizing these vaccines' safety, efficacy, and scalability for global application. Through an in-depth analysis of the mechanisms, clinical outcomes, and potential of DC-based vaccines, this paper underscores their promising prospects as an essential element of a comprehensive HIV eradication strategy worldwide.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
万能图书馆的应助被tayyy采纳,获得10
刚刚
范志鹏发布了新的文献求助10
1秒前
1秒前
苒苒发布了新的文献求助10
1秒前
面包恐龙发布了新的文献求助10
1秒前
molihuakai的应助被7Wen采纳,获得10
2秒前
ldz完成签到 ,获得积分20
2秒前
wobisheng完成签到,获得积分10
2秒前
3秒前
晚风与海盐完成签到 ,获得积分10
3秒前
波风水门发布了新的文献求助10
3秒前
Jason完成签到 ,获得积分10
3秒前
6秒前
8秒前
面包恐龙完成签到,获得积分10
8秒前
8秒前
RolfHoward完成签到,获得积分10
8秒前
8秒前
小赵爱漂亮完成签到 ,获得积分10
9秒前
羊_完成签到,获得积分10
9秒前
11秒前
傻子发布了新的文献求助20
12秒前
12秒前
12秒前
Twinkle发布了新的文献求助10
13秒前
SciGPT的应助被威武的皮卡丘采纳,获得10
13秒前
秋风的应助被Linkkk采纳,获得10
13秒前
14秒前
完美世界的应助被科研通管家采纳,获得10
14秒前
yang完成签到 ,获得积分10
14秒前
CarryLJR的应助被科研通管家采纳,获得10
14秒前
14秒前
Hello的应助被科研通管家采纳,获得10
14秒前
DW的应助被科研通管家采纳,获得10
14秒前
酷波er的应助被科研通管家采纳,获得10
14秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
14秒前
今后的应助被科研通管家采纳,获得10
14秒前
n01W97的应助被科研通管家采纳,获得20
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189382
求助须知:如何正确求助?哪些是违规求助? 9576691
关于积分的说明 21849410
捐赠科研通 7787318
什么是DOI,文献DOI怎么找? 3435538
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509